BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12485348)

  • 1. Pharmacokinetics and toxicity of bromide following high-dose oral potassium bromide administration in healthy Beagles.
    March PA; Podell M; Sams RA
    J Vet Pharmacol Ther; 2002 Dec; 25(6):425-32. PubMed ID: 12485348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of potassium bromide in adult horses.
    Raidal SL; Edwards S
    Aust Vet J; 2008 May; 86(5):187-93. PubMed ID: 18454837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of potassium bromide in adult horses.
    Raidal SL; Edwards S
    Aust Vet J; 2005 Jul; 83(7):425-30. PubMed ID: 16035184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of bromide in adult sheep following oral and intravenous administration.
    Quast TA; Combs MD; Edwards SH
    Aust Vet J; 2015; 93(1-2):20-5. PubMed ID: 25622704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic properties of bromide in dogs after the intravenous and oral administration of single doses.
    Trepanier LA; Babish JG
    Res Vet Sci; 1995 May; 58(3):248-51. PubMed ID: 7659850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and clinical use of bromide in cats.
    Boothe DM; George KL; Couch P
    J Am Vet Med Assoc; 2002 Oct; 221(8):1131-5. PubMed ID: 12387381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dietary chloride content on the elimination of bromide by dogs.
    Trepanier LA; Babish JG
    Res Vet Sci; 1995 May; 58(3):252-5. PubMed ID: 7659851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromide toxicosis secondary to renal insufficiency in an epileptic dog.
    Nichols ES; Trepanier LA; Linn K
    J Am Vet Med Assoc; 1996 Jan; 208(2):231-3. PubMed ID: 8567378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bromide concentrations following loading dose in epileptic dogs.
    Gindiciosi B; Palus V; Eminaga S; Villiers E; Bruto Cherubini G
    J Small Anim Pract; 2014 Feb; 55(2):108-11. PubMed ID: 24433448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and clinical utility of sodium bromide (NaBr) as an estimator of extracellular fluid volume in horses.
    Fielding CL; Magdesian KG; Elliott DA; Craigmill AL; Wilson WD; Carlson GP
    J Vet Intern Med; 2003; 17(2):213-7. PubMed ID: 12683623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of three infusion fluids with different sodium chloride contents on steady-state serum concentrations of bromide in dogs.
    Fukunaga K; Matsumoto H; Wate M; Misawa K; Saito M; Matsuda H; Orito K
    J Vet Pharmacol Ther; 2018 Oct; 41(5):684-690. PubMed ID: 30020534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
    Boothe DM; Perkins J
    J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of phenobarbital in dogs after multiple oral administration.
    Ravis WR; Nachreiner RF; Pedersoli WM; Houghton NS
    Am J Vet Res; 1984 Jul; 45(7):1283-6. PubMed ID: 24049884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic administration of phenobarbital, or bromide, on pharmacokinetics of levetiracetam in dogs with epilepsy.
    Muñana KR; Nettifee-Osborne JA; Papich MG
    J Vet Intern Med; 2015; 29(2):614-9. PubMed ID: 25711374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic serum drug concentrations in epileptic dogs treated with potassium bromide alone or in combination with other anticonvulsants: 122 cases (1992-1996).
    Trepanier LA; Van Schoick A; Schwark WS; Carrillo J
    J Am Vet Med Assoc; 1998 Nov; 213(10):1449-53. PubMed ID: 9828942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of N-nitrosodimethylamine in beagles.
    Gombar CT; Pylypiw HM; Harrington GW
    Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic properties of toceranib phosphate (Palladia, SU11654), a novel tyrosine kinase inhibitor, in laboratory dogs and dogs with mast cell tumors.
    Yancey MF; Merritt DA; Lesman SP; Boucher JF; Michels GM
    J Vet Pharmacol Ther; 2010 Apr; 33(2):162-71. PubMed ID: 20444041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and cerebrospinal fluid pharmacokinetics of cytosine arabinoside in dogs.
    Scott-Moncrieff JC; Chan TC; Samuels ML; Cook JR; Coppoc GL; DeNicola DB; Richardson RC
    Cancer Chemother Pharmacol; 1991; 29(1):13-8. PubMed ID: 1742843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, bioavailability, and hemodynamic effects of trazodone after intravenous and oral administration of a single dose to dogs.
    Jay AR; Krotscheck U; Parsley E; Benson L; Kravitz A; Mulligan A; Silva J; Mohammed H; Schwark WS
    Am J Vet Res; 2013 Nov; 74(11):1450-6. PubMed ID: 24168312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.